Archives des Discover GENIM - Toulouse Cancer Research Center

Cancer: a key mechanism for improving immunotherapies identified by a Toulouse team

30 Jun 2023 | Discover GENIM, Discover home page

Cancer: a key mechanism for improving immunotherapies identified by a Toulouse team Cancer, Immunology, Immunotherapy, Lymphocytes, Depletion. Ludovic Martinet Team GENIM Genomic and immunology of myeloma A team from the Centre de Recherches en Cancérologie de...

Heterogeneity in long-term outcomes for R-ISS stage II in newly diagnosed multiple myeloma patients

5 Oct 2022 | Discover GENIM, Discover home page

Heterogeneity in long-term outcomes for R-ISS stage II in newly diagnosed multiple myeloma patients Multiple myeloma, Cytogenetics, Prognosis Anaïs Schavgoulidze – Team GENIM – Genomic and Immunology of myeloma Multiple myeloma (MM) is characterized by...

More news

18 Jan 2019 | Dicover R'nBlood, Discover DIAD, Discover DynAct, Discover GENIM, Discover IGAALD, Discover ImPact, Discover INOV, Discover Melasphinx, Discover METAML, Discover Micropanc, Discover NetB(IO)², Discover NoLymIT, Discover ONCOSARC, Discover RADOPT, Discover RNAreg, Discover SigDyn, Discover Signather, Discover T2i

Very soon more news from this team to follow….

Cancer: a key mechanism for improving immunotherapies identified by a Toulouse team

Heterogeneity in long-term outcomes for R-ISS stage II in newly diagnosed multiple myeloma patients

More news

Pin It on Pinterest